Sign in to continue:

Wednesday, March 25th, 2026

ACM Research (Shanghai) Announces Proposed Profit Distribution Plan for Fiscal Year 2025 and Continued R&D Investment Growth

ACM Research, Inc. Announces Proposed Profit Distribution Plan for Fiscal Year 2025 for Subsidiary ACM Research (Shanghai), Inc.

FREMONT, CA, March 24, 2026 – ACM Research, Inc. (“ACM Research” or the “Company”) has announced that its operating subsidiary, ACM Research (Shanghai), Inc. (“ACM Shanghai”), which is listed on the Sci-Tech Innovation Board of the Shanghai Stock Exchange, has released a significant proposal regarding its profit distribution for the fiscal year 2025. This development could have implications for both ACM Research and its shareholders, given the involvement of its key subsidiary and the capital allocation strategy.

Key Points of the Announcement

  • Dividend Proposal: ACM Shanghai’s board has proposed a cash dividend of RMB 6.233 per 10 shares (inclusive of tax) for fiscal year 2025. No bonus shares will be issued, and there will be no conversion of capital reserves into share capital.
  • Record Date and Implementation: The dividend will be calculated based on the total share capital registered on the equity distribution record date, with the specific date to be provided in a future implementation announcement. The amount will be adjusted if there is a change in share capital between the announcement and the record date, but the total distribution amount will remain unchanged.
  • Approval Process: The plan has already been approved by ACM Shanghai’s Board of Directors and is subject to approval by shareholders at the 2026 Annual General Meeting of Shareholders.
  • Profitability and Retained Earnings: According to the audit report, ACM Shanghai’s parent company after-tax net profit for fiscal year 2025 was RMB 1,167,854,942.28. After statutory deductions and adjustments, the distributable profit as of December 31, 2025 was RMB 3,340,213,236.58.
  • Dividend Payout Ratio and Share Repurchase: The total proposed cash dividend and share repurchase for 2025 is RMB 349,022,682.22 (inclusive of tax), representing 25.00% of the net profit attributable to shareholders of ACM Shanghai for the year. The share repurchase amount for the year was RMB 50,012,340.46.
  • Historical Comparison: Over the past three fiscal years, ACM Shanghai paid cash dividends of RMB 299,010,341.76 (2025), RMB 288,252,734.66 (2024), and RMB 273,189,145.72 (2023).
  • R&D Commitment: Over the last three fiscal years, ACM Shanghai invested a total of RMB 2,751,547,232.45 in research and development, accounting for 16.89% of its total revenue of RMB 16,292,253,365.47 during the same period. This ratio exceeds the 15% threshold, highlighting a strong ongoing commitment to innovation and technology leadership.

Important Details and Potential Share Price Impact

  • Dividend Below 30% of Net Profit: Although the combined cash dividend and share repurchase represents 25.00% of net profit (below the 30% benchmark), management has provided a detailed justification:

    • ACM Shanghai operates in a capital- and technology-intensive industry, requiring significant and continuous investment in R&D to maintain competitive advantage and support new product development.
    • The company is in a rapid growth phase, with healthy year-on-year revenue and profit increases. Management believes retaining more earnings will sustain this momentum and support future expansion.
    • Retained profits will be used to fund operational, production, and R&D needs, supporting long-term growth and value creation for shareholders.
  • Shareholder Participation: ACM Shanghai is providing minority shareholders with multiple avenues to participate in decision-making on dividend policy, including online and in-person voting at General Meetings, and active investor communications via various channels.
  • No Trigger of Risk Warnings: ACM Shanghai confirms that it has not triggered circumstances that would require additional risk warnings under STAR Market Listing Rules.
  • Conditionality and Forward-Looking Statements: The proposed dividend plan is subject to approval at the 2026 ACM Shanghai Annual General Meeting. The company cautions investors that forward-looking statements are subject to risks and uncertainties, including shareholder approval and potential changes in regulations or business conditions.
  • Potential Price Sensitivity: The dividend proposal, payout ratio, and continued high R&D investment are all factors that could influence investor sentiment and the share price of both ACM Research, Inc. (NASDAQ: ACMR) and ACM Shanghai. The below-benchmark payout ratio may disappoint some income-focused investors, but the rationale of supporting innovation and future growth might appeal to growth-oriented shareholders. The company’s strong financial position, rising profits, and robust cash reserves are positive signals.

Summary Table of Key Financial Indicators

Item 2025 2024 2023
Total Cash Dividends (RMB) 299,010,341.76 288,252,734.66 273,189,145.72
Total Share Repurchase (RMB) 50,012,340.46 0 0
Net Profit Attributable to Shareholders (RMB) 1,395,929,467.13 1,153,188,090.00 860,452,222.14
Aggregate R&D Expenditure (last 3 years, RMB) 2,751,547,232.45
Aggregate Revenue (last 3 years, RMB) 16,292,253,365.47
R&D as % of Revenue (last 3 years) 16.89%

Conclusion

The announcement of ACM Shanghai’s proposed 2025 profit distribution plan is a significant corporate development, reflecting the company’s balancing act between rewarding shareholders and investing in future growth. The company’s strong financials, ongoing R&D commitment, and detailed rationale for a below-benchmark dividend payout are all key points for investors to consider. Shareholder approval at the upcoming 2026 AGM will be a critical milestone to watch.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors are advised to conduct their own due diligence and consult professional advisers before making any investment decisions. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied herein.

View ACM Research, Inc. Historical chart here



Immersion Corporation 2026 10-K/A Filing: Exhibits, Signatures & Compliance Disclosures

Immersion Corporation Files Amendment No. 1 to Annual Report...

CytoDyn Inc. Files SEC Form 8-K Announcing Extension of Convertible Note Maturity to April 2026

CytoDyn Inc. Announces Major Extension of Convertible Note M...

Smithfield Foods 2025 Annual Report: Financial Overview, Business Segments, and SEC Filings

Smithfield Foods Inc. 2025 Annual Report - Investor Highligh...

   Ad